Skip to main content

Table 2 Pulmonary function on cilostazol and placebo treatments in patients with bronchial asthma

From: Phosphodiesterase 3 inhibition and cough in elderly asthmatics

 

Run-in

Placebo

Wash out

Cilostazol

FVC as % pred. (%)

102.3 ± 5.7

104.7 ± 5.8

102.1 ± 5.1

108.4 ± 4.7

FEV1 as% pred. (%)

98.5 ± 8.2

100.4 ± 7.7

98.5 ± 6.6

106.3 ± 7.3

  1. Data are shown as mean value ± standard error of the mean.